Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial. [PDF]
Wang Y +16 more
europepmc +1 more source
Aprepitant, a Neurokinin-1 Receptor Antagonist, as a Disruptive Drug for the Treatment of Pediatric Cancer. [PDF]
Rosso M, Alcaide C, Muñoz M.
europepmc +1 more source
Adverse Event Reporting Patterns Associated with Concomitant Use of 5-HT3 and NK-1 Receptor Antagonists: A Large-Scale Spontaneous-Reporting Analysis. [PDF]
Zhao R +7 more
europepmc +1 more source
The neuronal network of small cell lung cancer: a narrative review of the role of the nervous system in the pathogenesis and progression. [PDF]
Gap M +6 more
europepmc +1 more source
Obesity, Oxidative Stress, and Inflammation in Precocious Puberty: Do All Roads Lead to the Hypothalamus? [PDF]
Bizerea-Moga TO +9 more
europepmc +1 more source
Substance P and NK-1R in Dengue: A First Serological Investigation. [PDF]
Mehboob R +7 more
europepmc +1 more source
Delayed and long-delayed chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a scoping review of reporting gaps. [PDF]
Iimura Y +11 more
europepmc +1 more source
A brain-first framework for perimenopause management: the case for non-invasive neuromodulation. [PDF]
Radytė E, Karvelyte I.
europepmc +1 more source
Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]
Avriyanti E +6 more
europepmc +1 more source

